UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent

Journal of thrombosis and haemostasis, 2012-07, Vol.10 (7), p.1303-1311

2012

Volltextzugriff (PDF)

The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study

Journal of thrombosis and thrombolysis, 2014-10, Vol.38 (3), p.275-284

2014

Volltextzugriff (PDF)

Dose Selection for a Direct and Selective Factor IXa Inhibitor and its Complementary Reversal Agent: Translating Pharmacokinetic and Pharmacodynamic Properties of the REG1 System to Clinical Trial Design

Journal of thrombosis and thrombolysis, 2011-07, Vol.32 (1), p.21-31

2011

Volltextzugriff (PDF)

Importance of the Organ-Independent Elimination of Cisatracurium

Anesthesia and analgesia, 1996-11, Vol.83 (5), p.1065-1071

1996

Volltextzugriff (PDF)

Bidirectional interaction of valproate and lamotrigine in healthy subjects

Clinical pharmacology and therapeutics, 1996-08, Vol.60 (2), p.145-156

1996

Volltextzugriff (PDF)

Pharmacokinetics of RheothRx Injection in Healthy Male Volunteers

Journal of pharmaceutical sciences, 1997-07, Vol.86 (7), p.808-812

1997

Volltextzugriff (PDF)

Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy

European heart journal, 2011-10, Vol.32 (19), p.2412-2419

2011

Volltextzugriff (PDF)

The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia

Anesthesiology (Philadelphia), 1994-06, Vol.80 (6), p.1296-1302

1994

Volltextzugriff (PDF)

The clinical pharmacokinetics of Vinorelbine (Navelbine)

Seminars in oncology, 1994-10, Vol.21 (5), p.21-27

1994

Volltextzugriff (PDF)

Pharmacokinetics and safety of lamotrigine (Lamictal®) in patients with epilepsy

Epilepsy research, 1991-11, Vol.10 (2), p.191-200

1991

Volltextzugriff (PDF)

Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors

Journal of clinical oncology, 1994-09, Vol.12 (9), p.1754-1763

1994

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Doxacurium in Young and Elderly Patients During Isoflurane Anesthesia

Anesthesia and analgesia, 1990-11, Vol.71 (5), p.498-502

1990

Volltextzugriff (PDF)

A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease

American journal of hematology, 2012-11, Vol.87 (11), p.1017-1021

2012

Volltextzugriff (PDF)

Pharmacokinetics of methylphenidate in man, rat and monkey

The Journal of pharmacology and experimental therapeutics, 1983-08, Vol.226 (2), p.382

1983

Volltextzugriff (PDF)

THE PHARMACOKINETICS OF 1954U89, 1, 3-DIAMINO-7-(1-ETHYLPROPYL)-8-METHYL-7H-PYRROLO-(3, 2-f )QUINAZOLINE, IN DOGS AND RATS AFTER INTRAVENOUS AND ORAL ADMINISTRATION

Biopharmaceutics & drug disposition, 1997-07, Vol.18 (5), p.433-442

1997

Volltextzugriff (PDF)

Contribution of Protein Binding to the Pharmacokinetics of the Ghrelin Receptor Agonist TZP-101 in Healthy Volunteers and Adults with Symptomatic Gastroparesis: Two Randomized, Double-Blind Studies and a Binding Profile Study

Clinical drug investigation, 2009-01, Vol.29 (6), p.409-418

2009

Volltextzugriff (PDF)

Final clinical and pharmacokinetic (PK) results from a phase 1 study of the novel N-cadherin (N-cad) antagonist, Exherin (ADH-1), in patients with refractory solid tumors stratified according to N-cad expression

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3016-3016

2006

Volltextzugriff (PDF)

Pharmacokinetics of Oral and Transdermal Triprolidine

Journal of clinical pharmacology, 1990-06, Vol.30 (6), p.572-575

1990

Volltextzugriff (PDF)

Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat

Journal of pharmacy and pharmacology, 1986-12, Vol.38 (12), p.883-887

1986

Volltextzugriff (PDF)

The effects of food and divided dosing on the bioavailability of oral vinorelbine

Cancer chemotherapy and pharmacology, 1996, Vol.39 (1-2), p.9-16

1996

Volltextzugriff (PDF)

Separation and quantitation of theophylline and paraxanthine by reversed-phase liquid chromatography

Clinical chemistry (Baltimore, Md.), 1980-03, Vol.26 (3), p.524

1980

Volltextzugriff (PDF)

Crisnatol mesylate : phase I dose escalation by extending infusion duration

Investigational new drugs, 1991-02, Vol.9 (1), p.41-47

1991

Volltextzugriff (PDF)

Influence of range of renal function and liver disease on predictability of creatinine clearance

Clinical pharmacology and therapeutics, 1981-04, Vol.29 (4), p.516-521

1981

Volltextzugriff (PDF)

Kinetic model for gentamicin dosing with the use of individual patient parameters

Clinical pharmacology and therapeutics, 1977-03, Vol.21 (3), p.362-369

1977

Volltextzugriff (PDF)

Factors Associated With Nephrotoxicity and Clinical Outcome in Patients Receiving Amikacin

Journal of clinical pharmacology, 1986-02, Vol.26 (2), p.79-86

1986

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(51)
Buchkapitel
(1)

Sprache

Englisch
(52)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent

The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study

Dose Selection for a Direct and Selective Factor IXa Inhibitor and its Complementary Reversal Agent: Translating Pharmacokinetic and Pharmacodynamic Properties of the REG1 System to Clinical Trial Design

Importance of the Organ-Independent Elimination of Cisatracurium

Bidirectional interaction of valproate and lamotrigine in healthy subjects

Pharmacokinetics of RheothRx Injection in Healthy Male Volunteers

Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy

The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia

The clinical pharmacokinetics of Vinorelbine (Navelbine)

Pharmacokinetics and safety of lamotrigine (Lamictal®) in patients with epilepsy

Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors

Pharmacokinetics and Pharmacodynamics of Doxacurium in Young and Elderly Patients During Isoflurane Anesthesia

A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease

Pharmacokinetics of methylphenidate in man, rat and monkey

THE PHARMACOKINETICS OF 1954U89, 1, 3-DIAMINO-7-(1-ETHYLPROPYL)-8-METHYL-7H-PYRROLO-(3, 2-f )QUINAZOLINE, IN DOGS AND RATS AFTER INTRAVENOUS AND ORAL ADMINISTRATION

Contribution of Protein Binding to the Pharmacokinetics of the Ghrelin Receptor Agonist TZP-101 in Healthy Volunteers and Adults with Symptomatic Gastroparesis: Two Randomized, Double-Blind Studies and a Binding Profile Study

Final clinical and pharmacokinetic (PK) results from a phase 1 study of the novel N-cadherin (N-cad) antagonist, Exherin (ADH-1), in patients with refractory solid tumors stratified according to N-cad expression

Pharmacokinetics of Oral and Transdermal Triprolidine

Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat

The effects of food and divided dosing on the bioavailability of oral vinorelbine

Separation and quantitation of theophylline and paraxanthine by reversed-phase liquid chromatography

Crisnatol mesylate : phase I dose escalation by extending infusion duration

Influence of range of renal function and liver disease on predictability of creatinine clearance

Kinetic model for gentamicin dosing with the use of individual patient parameters

Factors Associated With Nephrotoxicity and Clinical Outcome in Patients Receiving Amikacin

Suchergebnisse filtern